CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT (Unaudited) - USD ($)
|
Total |
Common Stock |
Additional Paid-in Capital |
Accumulated Deficit |
Accumulated Other Comprehensive Loss, Net |
Beginning balance (shares) at Dec. 31, 2020 |
|
5,949,463
|
|
|
|
Beginning balance at Dec. 31, 2020 |
$ (15,540,812)
|
$ 5,949
|
$ 110,107,170
|
$ (123,665,970)
|
$ (1,987,961)
|
Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
Net income (loss) |
408,295
|
|
|
408,295
|
|
Share-based compensation to employees |
4,471
|
|
4,471
|
|
|
Accretion of Series A redeemable convertible preferred stock |
(197,114)
|
|
(197,114)
|
|
|
Dividends on Series A redeemable convertible preferred stock |
(277,170)
|
|
(277,170)
|
|
|
Foreign currency translation |
86,398
|
|
|
|
86,398
|
Ending balance (shares) at Mar. 31, 2021 |
|
5,949,463
|
|
|
|
Ending balance at Mar. 31, 2021 |
(15,515,932)
|
$ 5,949
|
109,637,357
|
(123,257,675)
|
(1,901,563)
|
Beginning balance (shares) at Dec. 31, 2020 |
|
5,949,463
|
|
|
|
Beginning balance at Dec. 31, 2020 |
(15,540,812)
|
$ 5,949
|
110,107,170
|
(123,665,970)
|
(1,987,961)
|
Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
Net income (loss) |
394,635
|
|
|
|
|
Accretion of Series A redeemable convertible preferred stock |
(285,814)
|
|
|
|
|
Dividends on Series A redeemable convertible preferred stock |
(848,898)
|
|
|
|
|
Foreign currency translation |
92,802
|
|
|
|
|
Ending balance (shares) at Sep. 30, 2021 |
|
7,074,364
|
|
|
|
Ending balance at Sep. 30, 2021 |
(12,487,667)
|
$ 7,074
|
112,671,753
|
(123,271,335)
|
(1,895,159)
|
Beginning balance (shares) at Mar. 31, 2021 |
|
5,949,463
|
|
|
|
Beginning balance at Mar. 31, 2021 |
(15,515,932)
|
$ 5,949
|
109,637,357
|
(123,257,675)
|
(1,901,563)
|
Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
Net income (loss) |
(362,300)
|
|
|
(362,300)
|
|
Sale of common stock in public offering, net of underwriting discounts and offering costs, Shares |
|
811,750
|
|
|
|
Sale of common stock in public offering, net of underwriting discounts and offering costs, Value |
2,737,770
|
$ 812
|
2,736,958
|
|
|
Share-based compensation to employees |
4,697
|
|
4,697
|
|
|
Shares issued in connection with vesting of restricted stock (shares) |
|
28,151
|
|
|
|
Shares issued in connection with vesting of restricted stock |
0
|
$ 28
|
(28)
|
|
|
Accretion of Series A redeemable convertible preferred stock |
(75,183)
|
|
(75,183)
|
|
|
Dividends on Series A redeemable convertible preferred stock |
(282,926)
|
|
(282,926)
|
|
|
Foreign currency translation |
(4,740)
|
|
|
|
(4,740)
|
Ending balance (shares) at Jun. 30, 2021 |
|
6,789,364
|
|
|
|
Ending balance at Jun. 30, 2021 |
(13,498,614)
|
$ 6,789
|
112,020,875
|
(123,619,975)
|
(1,906,303)
|
Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
Net income (loss) |
348,640
|
|
|
348,640
|
|
Sale of common stock in public offering, net of underwriting discounts and offering costs, Shares |
|
285,000
|
|
|
|
Sale of common stock in public offering, net of underwriting discounts and offering costs, Value |
948,566
|
$ 285
|
948,281
|
|
|
Share-based compensation to employees |
4,916
|
|
4,916
|
|
|
Accretion of Series A redeemable convertible preferred stock |
(13,517)
|
|
(13,517)
|
|
|
Dividends on Series A redeemable convertible preferred stock |
(288,802)
|
|
(288,802)
|
|
|
Foreign currency translation |
11,144
|
|
|
|
11,144
|
Ending balance (shares) at Sep. 30, 2021 |
|
7,074,364
|
|
|
|
Ending balance at Sep. 30, 2021 |
(12,487,667)
|
$ 7,074
|
112,671,753
|
(123,271,335)
|
(1,895,159)
|
Beginning balance (shares) at Dec. 31, 2021 |
|
7,082,276
|
|
|
|
Beginning balance at Dec. 31, 2021 |
(12,965,983)
|
$ 7,082
|
112,349,613
|
(123,462,638)
|
(1,860,040)
|
Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
Net income (loss) |
(1,109,406)
|
|
|
(1,109,406)
|
|
Share-based compensation to employees |
8,184
|
|
8,184
|
|
|
Accretion of Series A redeemable convertible preferred stock |
(14,815)
|
|
(14,815)
|
|
|
Dividends on Series A redeemable convertible preferred stock |
(300,921)
|
|
(300,921)
|
|
|
Foreign currency translation |
33,510
|
|
|
|
33,510
|
Ending balance (shares) at Mar. 31, 2022 |
|
7,082,276
|
|
|
|
Ending balance at Mar. 31, 2022 |
(14,349,431)
|
$ 7,082
|
112,042,061
|
(124,572,044)
|
(1,826,530)
|
Beginning balance (shares) at Dec. 31, 2021 |
|
7,082,276
|
|
|
|
Beginning balance at Dec. 31, 2021 |
(12,965,983)
|
$ 7,082
|
112,349,613
|
(123,462,638)
|
(1,860,040)
|
Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
Net income (loss) |
(1,819,260)
|
|
|
|
|
Accretion of Series A redeemable convertible preferred stock |
(90,420)
|
|
|
|
|
Dividends on Series A redeemable convertible preferred stock |
(1,030,365)
|
|
|
|
|
Foreign currency translation |
170,375
|
|
|
|
|
Ending balance (shares) at Sep. 30, 2022 |
|
7,111,801
|
|
|
|
Ending balance at Sep. 30, 2022 |
(15,700,382)
|
$ 7,112
|
111,264,069
|
(125,281,898)
|
(1,689,665)
|
Beginning balance (shares) at Mar. 31, 2022 |
|
7,082,276
|
|
|
|
Beginning balance at Mar. 31, 2022 |
(14,349,431)
|
$ 7,082
|
112,042,061
|
(124,572,044)
|
(1,826,530)
|
Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
Net income (loss) |
(931,226)
|
|
|
(931,226)
|
|
Share-based compensation to employees |
19,102
|
|
19,102
|
|
|
Shares issued in connection with vesting of restricted stock (shares) |
|
29,525
|
|
|
|
Shares issued in connection with vesting of restricted stock |
0
|
$ 30
|
(30)
|
|
|
Accretion of Series A redeemable convertible preferred stock |
(35,582)
|
|
(35,582)
|
|
|
Dividends on Series A redeemable convertible preferred stock |
(338,428)
|
|
(338,428)
|
|
|
Foreign currency translation |
110,861
|
|
|
|
110,861
|
Ending balance (shares) at Jun. 30, 2022 |
|
7,111,801
|
|
|
|
Ending balance at Jun. 30, 2022 |
(15,524,704)
|
$ 7,112
|
111,687,123
|
(125,503,270)
|
(1,715,669)
|
Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
Net income (loss) |
221,372
|
|
|
221,372
|
|
Share-based compensation to employees |
7,985
|
|
7,985
|
|
|
Accretion of Series A redeemable convertible preferred stock |
(40,023)
|
|
(40,023)
|
|
|
Dividends on Series A redeemable convertible preferred stock |
(391,016)
|
|
(391,016)
|
|
|
Foreign currency translation |
26,004
|
|
|
|
26,004
|
Ending balance (shares) at Sep. 30, 2022 |
|
7,111,801
|
|
|
|
Ending balance at Sep. 30, 2022 |
$ (15,700,382)
|
$ 7,112
|
$ 111,264,069
|
$ (125,281,898)
|
$ (1,689,665)
|